These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1398 related articles for article (PubMed ID: 8790483)

  • 21. A randomised trial of skin photography as an aid to screening skin lesions in older males.
    Hanrahan PF; D'Este CA; Menzies SW; Plummer T; Hersey P
    J Med Screen; 2002; 9(3):128-32. PubMed ID: 12370325
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnosis and management costs of suspicious skin lesions from a population-based melanoma screening programme.
    Gordon L; Youl PH; Elwood M; Janda M; Ring IT; Lowe JB; Aitken JF
    J Med Screen; 2007; 14(2):98-102. PubMed ID: 17626710
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Economic evaluation of skin cancer prevention in Australia.
    Shih ST; Carter R; Sinclair C; Mihalopoulos C; Vos T
    Prev Med; 2009 Nov; 49(5):449-53. PubMed ID: 19747936
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Melanoma epidemiology of Austria reveals gender-related differences.
    Duschek N; Skvara H; Kittler H; Delir G; Fink A; Pinkowicz A; Waldhör T
    Eur J Dermatol; 2013; 23(6):872-8. PubMed ID: 24184485
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of the German skin cancer screening programme on melanoma incidence and indicators of disease severity.
    Trautmann F; Meier F; Seidler A; Schmitt J
    Br J Dermatol; 2016 Nov; 175(5):912-919. PubMed ID: 27203791
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reducing mortality in individuals at high risk for advanced melanoma through education and screening.
    Geller AC; Swetter SM; Oliveria S; Dusza S; Halpern AC
    J Am Acad Dermatol; 2011 Nov; 65(5 Suppl 1):S87-94. PubMed ID: 22018072
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A population-based study of cutaneous melanoma in Alberta, Canada (1993-2002).
    Metelitsa AI; Dover DC; Smylie M; de Gara CJ; Lauzon GJ
    J Am Acad Dermatol; 2010 Feb; 62(2):227-32. PubMed ID: 20018405
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Australian experience in sun protection and screening for melanoma.
    McCarthy WH
    J Surg Oncol; 2004 Jul; 86(4):236-45. PubMed ID: 15221930
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disparities in melanoma incidence and mortality in South-Eastern Europe: Increasing incidence and divergent mortality patterns. Is progress around the corner?
    Barbaric J; Sekerija M; Agius D; Coza D; Dimitrova N; Demetriou A; Safaei Diba C; Eser S; Gavric Z; Primic-Zakelj M; Zivkovic S; Zvolsky M; Bray F; Coebergh JW; Znaor A
    Eur J Cancer; 2016 Mar; 55():47-55. PubMed ID: 26773419
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Screening program reduced melanoma mortality at the Lawrence Livermore National Laboratory, 1984 to 1996.
    Schneider JS; Moore DH; Mendelsohn ML
    J Am Acad Dermatol; 2008 May; 58(5):741-9. PubMed ID: 18068264
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of skin cancer screening and secondary prevention campaigns on skin cancer incidence and mortality: A systematic review.
    Brunssen A; Waldmann A; Eisemann N; Katalinic A
    J Am Acad Dermatol; 2017 Jan; 76(1):129-139.e10. PubMed ID: 27707591
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Health-related quality of life in early breast cancer.
    Groenvold M
    Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Planning for a possible national colorectal cancer screening programme.
    Garvican L
    J Med Screen; 1998; 5(4):187-94. PubMed ID: 9934649
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An estimate of the annual direct cost of treating cutaneous melanoma.
    Tsao H; Rogers GS; Sober AJ
    J Am Acad Dermatol; 1998 May; 38(5 Pt 1):669-80. PubMed ID: 9591809
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Why a randomized melanoma screening trial is not a good idea.
    Halvorsen JA; Løberg M; Gjersvik P; Roscher I; Veierød MB; Robsahm TE; Nilsen LTN; Kalager M; Bretthauer M
    Br J Dermatol; 2018 Aug; 179(2):532-533. PubMed ID: 29893490
    [No Abstract]   [Full Text] [Related]  

  • 36. How has the impact of 'care pathway technologies' on service integration in stroke care been measured and what is the strength of the evidence to support their effectiveness in this respect?
    Allen D; Rixson L
    Int J Evid Based Healthc; 2008 Mar; 6(1):78-110. PubMed ID: 21631815
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Epidemiology and prevention of melanoma].
    Grob JJ; Richard MA
    Rev Prat; 2004 Jun; 54(11):1181-6. PubMed ID: 15496024
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Screening for cutaneous melanoma by skin self-examination.
    Berwick M; Begg CB; Fine JA; Roush GC; Barnhill RL
    J Natl Cancer Inst; 1996 Jan; 88(1):17-23. PubMed ID: 8847720
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Screening, early detection, and trends for melanoma: current status (2000-2006) and future directions.
    Geller AC; Swetter SM; Brooks K; Demierre MF; Yaroch AL
    J Am Acad Dermatol; 2007 Oct; 57(4):555-72; quiz 573-6. PubMed ID: 17870429
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trends in prognostic factors and survival from cutaneous melanoma in Yorkshire, UK and New South Wales, Australia between 1993 and 2003.
    Downing A; Yu XQ; Newton-Bishop J; Forman D
    Int J Cancer; 2008 Aug; 123(4):861-6. PubMed ID: 18500743
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 70.